Search - Université de Rennes Access content directly

Filter your results

5 Results
authFullName_s : Amelie Fouque

New pi3k​/akt​/mtor inhibitors and pharmaceutical uses thereof

Mickael Jean , Amelie Fouque , Patrick Legembre , Pierre van de Weghe
France, Patent n° : WO 2015044229 / EP 2853530. 2015
Patents hal-01139914v1
Image document

The cleaved FAS ligand activates the Na+/H+ exchanger NHE1 through Akt/ROCK1 to stimulate cell motility

Michaël Monet , Mallorie Poet , Sébastien Tauzin , Amelie Fouque , Auréa Cophignon et al.
Scientific Reports, 2016, 6 (1), pp.28008. ⟨10.1038/srep28008⟩
Journal articles hal-01334067v1

CD95-Mediated Proton Regulation

Sébastien Tauzin , Amelie Fouque , Dominique Lagadic-Gossmann , Pierre Vacher , Patrick Legembre et al.
CD95: Methods and Protocols, Methods in Molecular Biology, vol. 1557,, 6 (1), pp.95-102, 2017, ⟨10.1007/978-1-4939-6780-3_9⟩
Book sections hal-02570274v1

A Novel Covalent mTOR Inhibitor, DHM25, Shows in Vivo Antitumor Activity against Triple-Negative Breast Cancer Cells

Amelie Fouque , Olivier Delalande , Mickael Jean , Remy Castellano , Emmanuelle Josselin et al.
Journal of Medicinal Chemistry, 2015, 58 (16), pp.6559-6573. ⟨10.1021/acs.jmedchem.5b00991⟩
Journal articles hal-01187307v1

Study of the CD95-Mediated Non-apoptotic Signaling Pathway: PI3K

Amelie Fouque , Patrick Legembre
CD95: Methods and Protocols, 1557, pp.103-110, 2017, Methods in Molecular Biology, ⟨10.1007/978-1-4939-6780-3_10⟩
Book sections hal-01447230v1